This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Yubin Qiu: Innovator in Anti-Betacellulin Antibodies
Introduction
Yubin Qiu is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-betacellulin antibodies. His work has implications for therapeutic applications, showcasing the potential of innovative antibody technologies.
Latest Patents
Yubin Qiu holds a patent for "Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules." This patent provides a comprehensive disclosure of anti-BTC antibodies, methods for producing these antibodies, pharmaceutical compositions that include them, and methods for their use. Additionally, the patent introduces multi-specific binding molecules, such as bispecific antibodies, which contain a BTC binding moiety and an anti-VEGF binding moiety.
Career Highlights
Yubin Qiu is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on cutting-edge research and development projects that aim to advance medical science and improve patient outcomes.
Collaborations
Yubin collaborates with talented professionals in his field, including Chad Eric Bigelow and Ana Maria Carrion, who contribute to the innovative environment at Novartis.
Conclusion
Yubin Qiu's work in the development of anti-betacellulin antibodies exemplifies the impact of innovation in biotechnology. His contributions are paving the way for new therapeutic solutions and enhancing our understanding of antibody applications.